YDES
NASDAQ · Biotechnology
Yd Bio Ltd
$6.95
+0.56 (+8.68%)
Financial Highlights (FY 2026)
Revenue
679.5K
Net Income
-9,513,536
Gross Margin
28.0%
Profit Margin
-1,392.6%
Rev Growth
—
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 28.0% | 43.0% | 43.0% | 43.0% |
| Operating Margin | -883.3% | 23.0% | 23.0% | 20.8% |
| Profit Margin | -1,392.6% | 23.8% | 21.7% | 19.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 679.5K | 122.20M | 119.09M | 134.19M |
| Gross Profit | 190.6K | 52.52M | 51.18M | 57.67M |
| Operating Income | -6,002,359 | 28.12M | 27.40M | 27.90M |
| Net Income | -9,513,536 | 29.08M | 25.78M | 25.78M |
| Gross Margin | 28.0% | 43.0% | 43.0% | 43.0% |
| Operating Margin | -883.3% | 23.0% | 23.0% | 20.8% |
| Profit Margin | -1,392.6% | 23.8% | 21.7% | 19.2% |
| Rev Growth | — | +2.9% | +5.6% | -10.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.50M | 239.43M | 188.25M | 198.79M |
| Total Equity | 263.82M | 534.41M | 574.88M | 548.17M |
| D/E Ratio | 0.01 | 0.45 | 0.33 | 0.36 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -6,016,586 | 41.35M | 38.15M | 43.54M |
| Free Cash Flow | — | 33.20M | 25.74M | 34.14M |